Sort by
Refine Your Search
-
Country
-
Program
-
Employer
- RMIT University
- Karolinska Institutet
- Technical University of Munich
- University of British Columbia
- University of Oslo
- ;
- ; University of Warwick
- Academic Europe
- Curtin University
- Heidelberg University Hospital
- Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- Leibniz
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- University Medical Centre Groningen (UMCG)
- University of Basel
- Université de Caen Normandie
- 11 more »
- « less
-
Field
-
of the diversity within the T cell immune response. Our long-term goal is that the fundamental knowledge we generate will contribute to improved vaccines and immunotherapies. The Gerlach group is part of
-
-temporal dynamic organisation of human T cell immunity in tissues. This will bring the next generation of immunotherapies to the level of tissue specificity. The department of Infection Immunology addresses
-
. As a PhD candidate you will focus on analyses of patient-related factors for outcome and chemotherapy and immunotherapy treatment response and toxicity in bladder cancer. The candidate will contribute
-
to impressive therapeutic effects, immunotherapies tend to take an increasingly important place in the treatment of many cancers such as lung or skin cancers. Immunotherapy consists of creating or strengthening a
-
3 May 2024 Job Information Organisation/Company Heidelberg University Hospital Department Department of Surgery Research Field Medical sciences » Cancer research Researcher Profile First Stage Researcher (R1) Recognised Researcher (R2) Country Germany Application Deadline 30 May 2024 - 23:59...
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal
-
such as radio-immunotherapy. Image analysis, programming and use of clinical software’s for treatment planning will be central components of the work. The project will concern both photon and particle
-
Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association | Dresden, Sachsen | Germany | 2 months ago
employment. Starting date: 01.06.2024 Job description:PhD Student (f/m/d) Pre-clinical development and validation of Adapter-RevCAR‐T-cell-system for immunotherapy of melanoma With cutting-edge research in
-
unknown chemokine can be used when developing next generation immunotherapies. Requirements Research FieldMedical sciencesEducation LevelMaster Degree or equivalent Skills/Qualifications Profile We
-
biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks to exploit tumor-specific glycosylation